ストックスクリーナーアプリを入手
23.33
1.13%
0.26
アフターアワーズ：
23.33
前日終値:
$23.07
開ける：
$23.1
24時間の取引高:
298.30K
Relative Volume:
0.69
時価総額：
$865.44M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+9.53%
1か月 パフォーマンス:
+9.94%
6か月 パフォーマンス:
+41.39%
1年 パフォーマンス:
+1.35%
1日の値動き範囲:
$22.20
$23.40
1週間の範囲:
$20.39
$23.40
52週間の値動き範囲:
$10.01
$26.04
Ceribell Inc Stock (CBLL) Company Profile
CBLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
23.33 | 855.80M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 開始されました | Raymond James | Strong Buy |
| 2025-06-24 | 開始されました | BTIG Research | Buy |
| 2025-04-04 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-11-05 | 開始されました | BofA Securities | Buy |
| 2024-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
すべてを表示
Ceribell Inc (CBLL) 最新ニュース
CeriBell, Inc.'s (NASDAQ:CBLL) Shares May Have Run Too Fast Too Soon - simplywall.st
Is CeriBell Inc. stock a buy on dips2025 Top Decliners & Long-Term Safe Return Strategies - ulpravda.ru
Aug Technicals: Why CeriBell Inc. stock could outperform in 2025Portfolio Risk Summary & High Return Trade Opportunity Guides - ulpravda.ru
Protara, Ceribell rise on FDA breakthrough designations - MSN
Ceribell’s Foehr sells $125k in shares after option exercise By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $1.68 million in shares By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $1.68 million in shares - Investing.com
Pittsburgh Post-GazetteCeriBell, Inc.Common Stock (Nasdaq:CBLL) Stock Quote - FinancialContent
Will CeriBell Inc. stock benefit from infrastructure spending2026 world cup usa national team group stage star players transition play winner prediction breakdown - ulpravda.ru
Ceribell director resigns to pursue other professional ventures - MSN
Ceribell Gets FDA Breakthrough Device Status - Medical Device and Diagnostic industry
Ceribell’s AI Stroke Detection Tool Gains FDA Breakthrough Status - Zenopa
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection - Yahoo Finance
FDA grants breakthrough designation for Ceribell’s stroke detection monitor By Investing.com - Investing.com Nigeria
Ceribell receives FDA breakthrough device designation for LVO SD monitor - TipRanks
Ceribell shares advance after FDA grants breakthrough device status - MSN
CeriBell (NASDAQ:CBLL) Hits New 12-Month HighHere's Why - MarketBeat
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool - TipRanks
Ceribell, Inc. Receives FDA Breakthrough Device Designation for LVO Stroke Solution - TradingView — Track All Markets
Protara, CeriBell rise on FDA breakthrough designations (TARA:NASDAQ) - Seeking Alpha
Ceribell receives FDA breakthrough device designation for LVO stroke detection - MarketScreener
Ceribell’s LVO Stroke Detection Monitor Wins FDA Breakthrough Nod - Medical Product Outsourcing
CeriBell stock climbs after FDA Breakthrough Device Designation By Investing.com - Investing.com Nigeria
FDA grants breakthrough designation for Ceribell’s stroke detection monitor - Investing.com
FDA highlights new brain monitor that may spot deadly hospital strokes sooner - Stock Titan
Ceribell director Lucian Iancovici resigns from board and committees By Investing.com - Investing.com Nigeria
Ceribell director Lucian Iancovici resigns from board and committees - Investing.com
Ceribell, Inc. Announces Board Resignation - TradingView — Track All Markets
CeriBell, Inc. Announces Resignation of Lucian Iancovici as Chair of the Nominating and Corporate Governance Committee and as Member of the Compensation Committee, Effective as of December 31, 2025 - marketscreener.com
CeriBell stock climbs after FDA Breakthrough Device Designation - Investing.com
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
CeriBell (NASDAQ:CBLL) CFO Sells $756,000.00 in Stock - MarketBeat
Ceribell’s CFO Blumberg sells $756k in shares By Investing.com - Investing.com Canada
Ceribell’s CFO Blumberg sells $756k in shares - Investing.com India
CeriBell (NASDAQ:CBLL) Trading 3.4% HigherHere's What Happened - MarketBeat
CeriBell, Inc. (CBLL) Eps Diluted (Quarterly) - Zacks Investment Research
CeriBell raises 2025 revenue guidance to $89M while targeting deeper hospital penetration and expanding pediatric market - MSN
Ceribell (CBLL) price target increased by 13.29% to 28.56 - MSN
Squarepoint Ops LLC Takes Position in CeriBell, Inc. $CBLL - MarketBeat
Can CeriBell Stock Hold Up When Markets Turn? - Trefis
CeriBell (CBLL) Price Target Increased by 13.29% to 28.56 - Nasdaq
Aug Catalysts: Will CeriBell Inc. stock rally after Fed decisions2025 Momentum Check & Safe Entry Point Identification - moha.gov.vn
Will CeriBell Inc. stock rally after Fed decisionsGlobal Markets & AI Enhanced Trade Execution Alerts - DonanımHaber
Ceribell Inc (CBLL) 財務データ
Ceribell Inc (CBLL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.31%
0.51%
大文字化:
|
ボリューム (24 時間):